The occurrence of the no-reflow phenomenon still represents an important clinical issue
during pPCI and can negate the benefits of restoring culprit-vessel patency. Novel promising …

No-reflow is one of the major causes of postinterventional rise of cardiac enzyme and
myocardial infarction (MI). This complication is associated with substantial morbidity and …

The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction
undergoing percutaneous coronary intervention - PMC Back to Top Skip to main content NIH …

The interventional cardiologist makes a provisional diagnosis of the no-reflow phenomenon
in the presence of an acute reduction in coronary flow despite a widely patent epicardial …

Optional statement No-reflow occurs in up to one third of patients with acute myocardial
infarction during acute percutaneous intervention, and occasionally during elective …

No-reflow is responsible for 40% of the primary percutaneous coronary intervention without
complete myocardial reperfusion despite successful reopening of the infarct-related artery …

The lack of reperfusion of myocardium after prolonged ischaemia that may occur despite
opening of the infarct-related artery is termed “no reflow”. No reflow or slow flow occurs in 3 …

Primary percutaneous angioplasty (pPCI), represents the reperfusion strategy of choice for
patients with STEMI according to current international guidelines of the European Society of …

At the conclusion of a primary percutaneous coronary intervention for ST-segment elevation
myocardial infarction, and after the cardiologist makes certain that there is no residual …

The phenomenon of no-reflow is defined as inadequate myocardial perfusion through a
given segment of the coronary circulation without angiographic evidence of mechanical …